3052
Helvetica Chimica Acta – Vol. 89 (2006)
and the mixture was stirred for 4 h. The crude product was purified by CC (CH2Cl2/Et2O 400 :1): 365 mg
(ca. 50%) of 40a. Yellowish crystals. M.p. 130–1338. IR: 3055m, 3029m, 2931vs, 2852s, 2804m, 1633w,
1597m, 1575m, 1493s, 1465m, 1442s, 1385w, 1365m, 1335s, 1323m, 1308m, 1266w, 1237m, 1221m,
1
1182w, 1155m, 1115s, 1098vs, 1034m, 981s, 895m, 861m, 774s, 763vs, 736vs, 697vs. H-NMR9): 7.75–6.97
(m, 15 arom. H); 6.19 (d, J=2.9, CH(3’)); 4.65 (d, J=2.9, CH(2’)); 2.43 (br. s, 2 C HN); 1.12 (br. s, 2
2
CH2); 0.97 (br. s, C H). 13C-NMR ((D6)DMSO): 149.2, 144.5, 141.5, 139.8 (4s, 3 arom. C, C(4’)); 133.1,
2
132.6, 129.5, 129.4, 128.6, 128.5, 128.3, 128.0, 127.8, 127.5, 127.1, 127.0, 126.8, 126.3, 126.1 (15d, 15
arom. CH); 117.0 (d, C (3’)); 78.8 (d, C (2’)); 71.4 (s, C (5’)); 50.2 (t, 2 C HN); 25.9 (t, 2 C H); 23.8 (t,
2
CH2). CI-MS (NH3): 398 (10, [M+1]+), 361 (10), 348 (30), 313 (100, [M+1À2piperidine]+), 299 (6), 86 (9).
8.2. cis- and trans-1-(2,5-Dihydro-4,5-diphenylthiophen-2-yl)piperidine (cis-40b and trans-40b, resp.).
According to GP B, 34 (1.2 mmol) in toluene (10 ml) and 2b (ca. 4 mmol) in toluene (ca. 50 ml) were
used. The soln. was stirred at 808 for 4 d. After total conversion of the starting material (TLC), the
soln. was cooled to r.t., the solvent was removed in vacuo, and the crude product was purified by CC (hex-
ane/AcOEt 10 :1+3% Et3N): 181 mg (49%) of a mixture of cis-40b and trans-40b, which was separated
by MPLC(hexane/AcOEt 20 :1 +2% Et3N) to give 60 mg (16%) of cis-40b and 50 mg (14%) of trans-
40b.
Data of cis-40b. Oily, yellowish crystals. M.p. 106–1238. IR (Golden Gate ATR): 2934w, 2849w,
2810w, 1644w, 1601w, 1574w, 1495w, 1454w, 1439w, 1392w, 1368w, 1338w, 1309w, 1245w, 1222w, 1149w,
1
1100m, 1076w, 1036w, 977w, 911w, 860w, 846w, 773w, 759m, 724m, 698s, 688m. H-NMR: 7.38–7.09 (m,
10 arom. H); 6.37 (dd, J=2.4, 2.0, CH(3’)); 5.92 (dd, J=2.4, 2.0, CH(5’)); 5.73 (t-like, J=2.0, CH(2’));
2.56 (t-like, 2 CH2N); 1.71–1.51 (m, 2 C H); 1.50–1.38 (m, C H). 13C-NMR: 144.6, 143.0, 134.9 (3s,
2
2
C(4’), 2 arom. C); 129.6, 128.7, 128.5, 128.3, 127.7, 127.0, 126.7 (7d, 10 arom. CH, C(3’)); 83.3 (d,
C(2’)); 55.7 (d, C (5’)); 50.2 (t, 2 C HN); 26.2 (t, 2 C H); 23.9 (t, C H). CI-MS (NH3): 291 (24), 290
2
2
2
(100, [M+1ÀS]+). Anal. calc. for C21H25NS (321.16): C78.46, H 7.21, N 4.36, S 9.97; found: C78.13,
H 6.82, N 4.29, S 9.54.
Crystals suitable for an X-ray crystal-structure determination were grown from Et2O/hexane by slow
evaporation of the solvent.
Data of trans-40b. Pale yellowish oily crystals. M.p. 110–1388. IR (Golden Gate ATR): 2933w, 2877w,
2851w, 2798w, 1575w, 1496w, 1446m, 1363w, 1331w, 1208w, 1149w, 1092m, 1034w, 977m, 850w, 820w, 768m,
754m, 726m, 714m, 693m. 1H-NMR: 7.33–7.07 (m, 10 arom. H); 6.31 (dd, Jꢀ2.5, 1.9, CH(3’)); 5.99 (dd,
J=5.1, 2.5, CH(5’)); 5.68 (dd, J=5.1, 1.9, CH(2’)); 2.63–2.47 (m, 2 C HN); 1.71–1.52 (m, C H);
2
2
1.49–1.42 (m, C H)). 13C-NMR: 145.9 (s, C (4’)); 142.6, 134.7 (2s, 2 arom. C); 129.5, 128.5, 128.2, 127.7,
2
127.6, 126.9 (6d, 10 arom. CH, C(3)); 83.3 (d, C (2’)); 57.3 (d, C (5’)); 49.7 (t, 2 C HN); 25.6 (t, 2 C H);
2
2
24.2 (t, C H). CI-MS (NH3): 291 (24), 290 (100, [M+1ÀS]+).
2
8.3. 1-(2,5-Dihydro-4-phenylthiophen-2-yl)piperidine (40c). According to GP B, 34 (1.3 mmol) in
CH2Cl2 (20 ml) and 2c (ca. 6 mmol) in THF (30 ml) were used. The crude product was purified by CC
(hexane/AcOEt 2 :1): 174 mg (55%) of 40c. Yellowish oily crystals. M.p. not measurable. IR: 2932vs,
2852s, 2816s, 2788s, 2748m, 1639w, 1598w, 1575w, 1496s, 1468m, 1450s, 1441s, 1429m, 1384m, 1365s,
1335s, 1321s, 1304s, 1282w, 1263w, 1247m, 1232s, 1213s, 1152s, 1128m, 1116s, 1099vs, 1075m, 1036m,
1
994s, 975s, 964m, 921m, 863s, 847s, 776s, 758vs, 748vs, 713vs, 687vs, 636m. H-NMR (CDCl3): 7.39–7.18
(m, 5 arom. H); 6.14 (q-like, =CH); 5.72 (q-like, CH(2’)); 3.93 (q-like, CH2(5’)); 2.50–2.36 (m, 2
CH2N); 1.57–1.36 (m, 3 C H). 13C-NMR: 142.2 (s, C (4’)); 134.3 (s, 1 arom. C); 127.6, 127.2, 125.1 (3d,
2
5 arom. CH); 125.0 (d, C (3’)); 83.4 (d, C (2’)); 48.6 (t, C (5’)); 36.8 (t, 2 C HN); 24.7, 23.3 (2t, 3 C H).
2
2
CI-MS (NH3): 246 (100, [M+1]+), 214 (86, [M+1ÀS]+), 86 (27, [piperidine+1]+).
Crystals suitable for an X-ray crystal-structure determination were grown from Et2O/hexane by slow
evaporation of the solvent.
8.4. 1-(4-Phenyl-1-thiaspiro[4.5]dec-3-en-2-yl)piperidine (40d). According to GP B, 34 (1.3 mmol) in
CH2Cl2 (10 ml) and 2d (ca. 4 mmol) in CH2Cl2 (ca. 50 ml) were used. To the soln. a cat. amount (5 mg) of
Rh2(OAc)4 was added, and the mixture was stirred at r.t. for 7 h. Then, the solvent was removed i.v., and
9
)
The spectra are not ꢁcleanꢂ because of fast decomposition of the substance.